Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Clin Nucl Med ; 49(5): 444-446, 2024 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-38389211

RESUMEN

ABSTRACT: A 69-year-old woman presented with a right clavicle pain. CT revealed a pathological fracture of the right clavicle, multiple osteolytic lesions, and a left cervical mass. 18 F-FDG PET/CT demonstrated a marked FDG uptake in the cervical mass and osteolytic lesions indicative of metastatic parathyroid cancer. 99m Tc-MIBI SPECT/CT revealed either faint or no uptake in the osteolytic lesions. However, a histopathological analysis after a parathyroidectomy and right clavicle biopsy confirmed the diagnosis of parathyroid cancer and the presence of benign brown tumors secondary to hyperparathyroidism. Postoperative imaging showed sclerotic change and a decreased FDG uptake in the bone lesions.


Asunto(s)
Neoplasias Óseas , Osteítis Fibrosa Quística , Neoplasias de las Paratiroides , Femenino , Humanos , Anciano , Fluorodesoxiglucosa F18 , Neoplasias de las Paratiroides/complicaciones , Tomografía Computarizada por Tomografía de Emisión de Positrones/métodos , Tecnecio Tc 99m Sestamibi , Tomografía Computarizada de Emisión de Fotón Único , Osteítis Fibrosa Quística/complicaciones , Neoplasias Óseas/secundario
2.
Clin Nucl Med ; 48(12): 1015-1020, 2023 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-37756474

RESUMEN

PURPOSE: The possibility of steroid administration inducing the extensive skeletal muscle uptake (ESMU) of FDG in PET scans was investigated. METHODS: From 8923 consecutive 18 F-FDG PET/CT scans taken at our hospital, 23 scans (15 patients) met adult age and ESMU-positive inclusion criteria. Among the 15 patients, 13 with both ESMU-positive and -negative scans were examined for association with steroid administration. RESULTS: Extensive skeletal muscle uptake was associated with a history of steroid administration ( χ2 test: P = 0.001). Notably, 20 ESMU-positive scans and 11 ESMU-negative scans were significantly different, with 0 to 95 days (median, 18.5 days) and 0 to 708 days (median, 319.0 days) since the last steroid administration, respectively (Mann-Whitney U test, P = 0.003). A significant correlation was observed between mean skeletal muscle SUV max and the number of days since the last steroid administration (Spearman rank correlation coefficient, ρ = -0.501, P = 0.004). Specifically, the degree of ESMU tended to decrease over time, after steroid administration. From multiple regression analysis, the number of days since the last steroid administration was significantly associated with mean SUV max ( P = 0.007), but the blood glucose level was not significant ( P = 0.204), revealing that the number of days since the last steroid administration was an independent risk factor. Multicollinearity was low (the variance inflation factor was 1.007 for both the number of days since the last steroid administration and blood glucose levels). CONCLUSIONS: Steroid administration within months before PET may be one cause of ESMU.


Asunto(s)
Fluorodesoxiglucosa F18 , Tomografía Computarizada por Tomografía de Emisión de Positrones , Adulto , Humanos , Radiofármacos , Glucemia , Tomografía de Emisión de Positrones , Músculo Esquelético , Esteroides
3.
Clin Nucl Med ; 48(2): 194-196, 2023 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-36179325

RESUMEN

ABSTRACT: A 38-year-old man with von Hippel-Lindau (VHL) disease and a history of renal cell carcinoma presented with a 2-month history of recurrent epistaxis. MRI revealed a microcystic tumor in the left ethmoid sinus with strong contrast enhancement. 18 F-FDG PET/CT showed FDG uptake (SUV max , 4.2) in the lesion. Under the suspicion of renal cell carcinoma metastasis, the patient underwent 2 surgical resections. However, based on the morphological and immunohistochemical findings, the patient was finally diagnosed with a VHL-associated microcystic adenoma of the ethmoid sinus, which is an extremely rare tumor that occurs in VHL disease.


Asunto(s)
Adenoma , Carcinoma de Células Renales , Neoplasias Renales , Enfermedad de von Hippel-Lindau , Masculino , Humanos , Adulto , Carcinoma de Células Renales/diagnóstico por imagen , Carcinoma de Células Renales/complicaciones , Enfermedad de von Hippel-Lindau/complicaciones , Enfermedad de von Hippel-Lindau/diagnóstico por imagen , Tomografía Computarizada por Tomografía de Emisión de Positrones , Fluorodesoxiglucosa F18 , Senos Etmoidales/diagnóstico por imagen , Senos Etmoidales/patología , Adenoma/complicaciones , Neoplasias Renales/diagnóstico por imagen , Neoplasias Renales/complicaciones
4.
Science ; 374(6569): 857-863, 2021 Nov 12.
Artículo en Inglés | MEDLINE | ID: mdl-34762472

RESUMEN

Memories are initially encoded in the hippocampus but subsequently consolidated to the cortex. Although synaptic plasticity is key to these processes, its precise spatiotemporal profile remains poorly understood. Using optogenetics to selectively erase long-term potentiation (LTP) within a defined temporal window, we found that distinct phases of synaptic plasticity play differential roles. The first wave acts locally in the hippocampus to confer context specificity. The second wave, during sleep on the same day, organizes these neurons into synchronously firing assemblies. Finally, LTP in the anterior cingulate cortex during sleep on the second day is required for further stabilization of the memory. This demonstrates the precise localization, timing, and characteristic contributions of the plasticity events that underlie the early phase of memory consolidation.


Asunto(s)
Región CA1 Hipocampal/fisiología , Consolidación de la Memoria , Plasticidad Neuronal , Animales , Inactivación por Luz Asistida por Cromóforo , Potenciales Postsinápticos Excitadores , Potenciación a Largo Plazo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Optogenética , Células Piramidales/fisiología , Ratas , Sueño , Sinapsis/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA